Table 1.
Characteristics | LSKS-SRLA (n = 87) | LSLA-SRLA (n = 159) | P |
---|---|---|---|
Age | 55.02 ± 10.44 | 53.99 ± 12.16 | 0.503 |
Gender | 0.212 | ||
Male | 51 | 80 | |
Female | 36 | 79 | |
BMI (kg/m2) | 26.39 ± 3.89 | 26.03 ± 4.04 | 0.501 |
pT stage | 0.981 | ||
T2 | 8 | 14 | |
T3 | 14 | 27 | |
T4a | 65 | 118 | |
pN stage | 0.745 | ||
N0 | 18 | 28 | |
N1 | 20 | 46 | |
N2 | 32 | 58 | |
N3 | 17 | 27 | |
pTNM stage | 0.868 | ||
IB | 3 | 7 | |
IIA | 8 | 13 | |
IIB | 14 | 20 | |
IIIA | 19 | 43 | |
IIIB | 29 | 56 | |
IIIC | 14 | 20 | |
Nerve invasion | 0.256 | ||
Yes | 11 | 29 | |
No | 76 | 130 | |
Lymphovascular invasion | 0.435 | ||
Yes | 16 | 36 | |
No | 71 | 123 | |
Type of tumor differentiation | 0.136 | ||
High | 34 | 48 | |
Moderate | 39 | 69 | |
Low | 14 | 42 |
LSKS-SRLA = laparoscopic splenic regional lymphadenectomy with spleen kept in situ; LSLA-SRLA = laparotomy with spleen lifted out of the abdomen.